FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases (FAST-01): Protocol for the First Prospective Feasibility Study
Emily Daugherty(Cincinnati Children's Hospital Medical Center), John C. Breneman(University of Cincinnati), Kenneth Russell(Siemens Healthcare (United States)), Claire McCann(Siemens Healthcare (United States)), Ricky A. Sharma(Siemens Healthcare (United States)), Deepak Khuntia(Mills Peninsula Health Services), Jennifer Woo(Siemens Healthcare (United States)), Eunsin Lee(Cincinnati Children's Hospital Medical Center), Mathieu Sertorio(University of Cincinnati Medical Center), Lisa Levine(Siemens Healthcare (United States)), Anthony Mascia(Cincinnati Children's Hospital Medical Center), Charles B. Simone(New York Proton Center), John P. Perentesis(University of Southern California), Jeffrey D. Bradley(Hospital of the University of Pennsylvania), Zhiyan Xiao(Cincinnati Children's Hospital Medical Center), Yong Zhang(Cincinnati Children's Hospital Medical Center)
Cited by 88
Related Papers
Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial
|Neuro-Oncology|2013|942
Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001
|Journal of Clinical Oncology|2020|827
Predicting Radiation Pneumonitis After Chemoradiation Therapy for Lung Cancer: An International Individual Patient Data Meta-analysis
|International Journal of Radiation Oncology*Biology*Physics|2013|673
Proton FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases
|JAMA Oncology|2022|557
A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases
|International Journal of Radiation Oncology*Biology*Physics|2002|508